Simeon Pollack (2011) “The rationale for using hydroxycarbamide in the treatment of sickle cell disease” (Haematologica 2011;96:488–491). Reply”, Haematologica. Pavia, Italy, 96(6), pp. e30-e30. doi: 10.3324/haematol.2011.046409.